 |
Howard Berman, PhD, Co-Founder and CEOCoya Therapeutics, Inc. (NASDAQ: COYA)“Coya Therapeutics is funded today because of the expertise and professionalism of the team at Allele Capital. Their knowledge of the scientific landscape and capital markets is superior. What struck me quite profoundly was their ability to quickly identify the value proposition of our underlying science and ask the right questions. Further, their institutional and accredited investor network is impressive, while the cost to access capital is much lower than traditional VCs, and certainly much faster. The team at Allele Capital are committed to doing things ethically, honestly, transparently, and quickly. All recipes necessary for success in a clinical-stage company like Coya that aims to deliver therapies to patients fastidiously and with compassion.” |
||
